Balchem Corp BCPC Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Mar 08, 2024 (filed on Mar 12, 2024)

Insider Name:

Tignor Michael Brent

Ownership Type:

Direct Ownership

Securities:

Stock Options (right to buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-4,200

Price:

--
Mar 08, 2024 (filed on Mar 12, 2024)

Insider Name:

Tignor Michael Brent

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,078

Price:

$158.22
Mar 08, 2024 (filed on Mar 12, 2024)

Insider Name:

Tignor Michael Brent

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-3,261

Price:

$157.07
Mar 08, 2024 (filed on Mar 12, 2024)

Insider Name:

Tignor Michael Brent

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

4,200

Price:

$85.40
Mar 04, 2024 (filed on Mar 06, 2024)

Insider Name:

Wineinger Matthew David

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-1,333

Price:

$156.89
Feb 26, 2024 (filed on Feb 27, 2024)

Insider Name:

Backus William A.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-100

Price:

$156.13
Feb 26, 2024 (filed on Feb 27, 2024)

Insider Name:

Backus William A.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-4,319

Price:

$155.66
Feb 26, 2024 (filed on Feb 27, 2024)

Insider Name:

Backus William A.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,581

Price:

$154.36
Feb 23, 2024 (filed on Feb 27, 2024)

Insider Name:

Backus William A.

Ownership Type:

Direct Ownership

Securities:

Stock Options (right to buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-3,700

Price:

--
Feb 23, 2024 (filed on Feb 27, 2024)

Insider Name:

Backus William A.

Ownership Type:

Direct Ownership

Securities:

Stock Options (right to buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-5,480

Price:

--

Filings by filing date

Mar 08, 2024 (filed on Mar 12, 2024)

Insider Name:

Tignor Michael Brent

Ownership Type:

Direct Ownership

Securities:

Stock Options (right to buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-4,200

Price:

--
Mar 08, 2024 (filed on Mar 12, 2024)

Insider Name:

Tignor Michael Brent

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,078

Price:

$158.22
Mar 08, 2024 (filed on Mar 12, 2024)

Insider Name:

Tignor Michael Brent

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-3,261

Price:

$157.07
Mar 08, 2024 (filed on Mar 12, 2024)

Insider Name:

Tignor Michael Brent

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

4,200

Price:

$85.40
Mar 04, 2024 (filed on Mar 06, 2024)

Insider Name:

Wineinger Matthew David

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-1,333

Price:

$156.89
Feb 23, 2024 (filed on Feb 27, 2024)

Insider Name:

Backus William A.

Ownership Type:

Direct Ownership

Securities:

Stock Options (right to buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-3,700

Price:

--
Feb 23, 2024 (filed on Feb 27, 2024)

Insider Name:

Backus William A.

Ownership Type:

Direct Ownership

Securities:

Stock Options (right to buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-5,480

Price:

--
Feb 26, 2024 (filed on Feb 27, 2024)

Insider Name:

Backus William A.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-100

Price:

$156.13
Feb 26, 2024 (filed on Feb 27, 2024)

Insider Name:

Backus William A.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-4,319

Price:

$155.66
Feb 26, 2024 (filed on Feb 27, 2024)

Insider Name:

Backus William A.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,581

Price:

$154.36

News

Biz Brief

Sector: Basic Materials	Industry: Specialty Chemicals

See Regulatory Filings on SEC

Company Contact

Address:	5 Paragon Drive MONTVALE NJ 07645
Tel:	N/A
Website:	https://balchem.com
IR:	See website

Key People

Theodore L. Harris Chairman of the Board, President, Chief Executive Officer	Martin Bengtsson Chief Financial Officer, Executive Vice President	M. Brent Tignor Chief Human Resource Officer, Senior Vice President
Hatsuki Miyata Executive Vice President, General Counsel, Secretary	Michael R. Sestrick Senior Vice President, Chief Technology Officer	Frederic Boned Senior Vice President, General Manager - Human Nutrition and Health
Job L. Van Gunsteren Senior Vice President, General Manager - Specialty Products	Jonathan H. Griffin Senior Vice President - Corporate Development	Martin L. Reid Senior Vice President, Chief Supply Chain Officer

Business Overview

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Financial Overview

For the fiscal year ended 31 December 2023, Balchem Corp revenues decreased 2% to $922.4M. Net income increased 3% to $108.5M. Revenues reflect Animal Nutrition & Health segment decrease of 9% to $238.3M, Other and Unallocated segment decrease of 66% to $7.4M, Foreign Countries segment decrease of 10% to $232.8M. Net income reflects Transtn&integration cost-Berrgstrom Acq decrease from $1M (expense) to $10.6M (income).

Employees:	1,302 as of Dec 31, 2023

Reporting Currency:	U.S. Dollars
Enterprise value:	$4,877M as of Dec 31, 2023
Annual revenue (TTM):	$922.44M as of Dec 31, 2023
EBITDA (TTM):	$210.60M as of Dec 31, 2023
Net annual income (TTM):	$108.54M as of Dec 31, 2023
Free cash flow (TTM):	$123.00M as of Dec 31, 2023
Net Debt Last Fiscal Year:	$247.34M as of Dec 31, 2023
Shares outstanding:	32,266,941 as of Feb 2, 2024
Index Membership:	S&P 600 Small Cap
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization